Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutability and hypermutation antagonize immunoglobulin codon optimality.
McGrath JJC, Park J, Troxell CA, Chervin JC, Li L, Kent JR, Changrob S, Fu Y, Huang M, Zheng NY, Wilbanks GD, Nelson SA, Sun J, Inghirami G, Madariaga MLL, Georgiou G, Wilson PC. McGrath JJC, et al. Among authors: fu y. Mol Cell. 2024 Dec 12:S1097-2765(24)00988-2. doi: 10.1016/j.molcel.2024.11.033. Online ahead of print. Mol Cell. 2024. PMID: 39708804
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.
Changrob S, Halfmann PJ, Liu H, Torres JL, McGrath JJC, Ozorowski G, Li L, Wilbanks GD, Kuroda M, Maemura T, Huang M, Zheng NY, Turner HL, Erickson SA, Fu Y, Yasuhara A, Singh G, Monahan B, Mauldin J, Srivastava K, Simon V, Krammer F, Sather DN, Ward AB, Wilson IA, Kawaoka Y, Wilson PC. Changrob S, et al. Among authors: fu y. J Clin Invest. 2023 Apr 17;133(8):e166844. doi: 10.1172/JCI166844. J Clin Invest. 2023. PMID: 36862518 Free PMC article.
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S, Fu Y, Guthmiller JJ, Halfmann PJ, Li L, Stamper CT, Dugan HL, Accola M, Rehrauer W, Zheng NY, Huang M, Wang J, Erickson SA, Utset HA, Graves HM, Amanat F, Sather DN, Krammer F, Kawaoka Y, Wilson PC. Changrob S, et al. Among authors: fu y. mBio. 2021 Dec 21;12(6):e0297521. doi: 10.1128/mBio.02975-21. Epub 2021 Nov 16. mBio. 2021. PMID: 34781736 Free PMC article. Clinical Trial.
Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike.
Wilson P, Changrob S, Fu Y, Guthmiller J, Halfmann P, Li L, Stamper C, Dugan H, Accola M, Rehrauer W, Zheng NY, Huang M, Wang J, Erickson S, Utset H, Graves H, Amanat F, Sather DN, Krammer F, Kawaoka Y. Wilson P, et al. Among authors: fu y. Res Sq [Preprint]. 2021 Jul 19:rs.3.rs-678247. doi: 10.21203/rs.3.rs-678247/v1. Res Sq. 2021. Update in: mBio. 2021 Dec 21;12(6):e0297521. doi: 10.1128/mBio.02975-21 PMID: 34312615 Free PMC article. Updated. Preprint.
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
Hou Y, Liang HL, Yu X, Liu Z, Cao X, Rao E, Huang X, Wang L, Li L, Bugno J, Fu Y, Chmura SJ, Wu W, Luo SZ, Zheng W, Arina A, Jutzy J, McCall AR, Vokes EE, Pitroda SP, Fu YX, Weichselbaum RR. Hou Y, et al. Among authors: fu yx, fu y. Sci Transl Med. 2021 Feb 24;13(582):eabb0130. doi: 10.1126/scitranslmed.abb0130. Sci Transl Med. 2021. PMID: 33627484 Free PMC article.
Advances and applications in single-cell and spatial genomics.
Wang J, Ye F, Chai H, Jiang Y, Wang T, Ran X, Xia Q, Xu Z, Fu Y, Zhang G, Wu H, Guo G, Guo H, Ruan Y, Wang Y, Xing D, Xu X, Zhang Z. Wang J, et al. Among authors: fu y. Sci China Life Sci. 2024 Dec 20. doi: 10.1007/s11427-024-2770-x. Online ahead of print. Sci China Life Sci. 2024. PMID: 39792333 Review.
20,424 results
You have reached the last available page of results. Please see the User Guide for more information.